Current Needs to Support Nasally Inhaled Products in USP–NF—Recommendation From the
Nasal Working Group of the International Pharmaceutical Consortium on Regulation and
Science
Jolyon P Mitchell, William H Doub, Jamie Clayton, Goncalo Farias, Sana Hosseini, Marcello Nuttini, Alyssa Rubino, Maria Smith, Enrico Zambell
Correspondence should be addressed to: Mingyan Chu, Principal Scientist, US
Pharmacopeia, 12601 Twinbrook Parkway, Rockville, MD 20852-1790; tel +1 301-816-8209;
email: mnc@usp.org.
